Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Parra, Marcela ^a   Liu, Xia ^a   Derrick, Steven C ^a   Yang, Amy ^a   Tian, Jinhua ^a   Kolibab, Kristopher ^a   Kumar, Sanjai ^a   Morris, Sheldon L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC PROTEIN; BCG VACCINE; CATHELICIDIN; EOSINOPHIL PEROXIDASE; LACTOFERRIN; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM; PLASMODIUM YOELII; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BCG VACCINE; CATHELICIDINS; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHIL PEROXIDASE; FEMALE; GENE EXPRESSION; IMMUNITY, INNATE; LACTOFERRIN; MALARIA; MICE; MICE, INBRED C57BL; PLASMODIUM YOELII; VACCINATION;

MURINAE; MUS; PLASMODIUM PARASITES; PLASMODIUM YOELII;

EID: 84879804481     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066115     Document Type: Article

References (45)

1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, et al. (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702.
2. Trunz BB, Fine P, Dye C, (2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367: 1173-1180.
3. Levine MI, Sackett M, (1946) Results of BCG immunization in New York City. Am Rev Tuberc 53: 517-532.
4. Velema JP AE, Gandaho T, Hounye FH, (1991) Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol 20: 474-479.
5. Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, et al. (2005) BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol 34: 540-547.
6. Post CL Victoria C, Valente JG, Leal Mdo C, Niobey FM, et al. (1992) Prognostic factors of hospital mortality from diarrhea or pneumonia in infants younger than 1 year old. A case-control study. Rev Saude Publica 26: 369-378.
7. El-Zein M, Parent M, Benedetti A, Rousseau MC, (2010) Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. Int J Epidemiol 39: 469-486.
8. Williams SK, Hoenig DM, Ghavamian R, Soloway M, (2010) Intravesical therapy for bladder cancer. Expert Opin Pharmacother 11: 947-958.
9. Ortiz-Ortiz L, Gonzalez-Mendoza A, Lamoyi E, (1975) A vaccination procedure against Trypanosoma cruzi infection in mice by nonspecific immunization. J Immunol 114: 1424-1425.
10. Tabbara KJ, O'Connor GR, Nozik RA, (1975) Effect of immunization with attenuated Mycobacterium bovis on experimental toxoplasmic retinochoroiditis. Am J Ophthalmol 79: 641-647.
11. Clark IA Allison AC, Cox FE, (1976) Protection of mice against Babesia and Plasmodium with BCG. Nature 259: 309-311.
12. Smrkovski LL, Strickland G, (1978) Rodent malaria: BCG-induced protection and immunosuppression. J Immunol 121: 1257-1261.
13. Merle CS, Cunha SS, Rodrigues LC, (2010) BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines 9: 209-222.
14. Trnka L, Danková D, Svandová E, (1994) Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis 75: 348-352.
15. Goter-Robinson C, Derrick S, Yang AL, Jeon BY, Morris SL, (2006) Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses. Vaccine 24: 3522-3529.
16. Lim J, Derrick SC, Kolibab K, Yang AL, Porcelli S, et al. (2009) Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array. Clin Vaccine Immunol 16: 122-126.
17. Méndez-Samperio P, Miranda E, Trejo A, (2008) Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guérin. Clin Vaccine Immunol 15: 1450-1455.
18. Méndez-Samperio P, (2010) The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Peptides 31: 1791-1798.
19. Kin NW, Chen Y, Stefanov EK, Gallo RL, Kearney JF, (2011) Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function. Eur J Immunol 41: 3006-3016.
20. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431.
21. Nizet V, Gallo RL, (2003) Cathelicidins and innate defense against invasive bacterial infection. Scand J Infect Dis 35: 670-679.
22. Arvidsson CM, Karpman D, (2012) The antimicrobial peptide cathelicidin protects mice against Escherichia coli O157:H7 mediated disease. PLoS One 7: e46476.
23. Rivas-Santiago B, Rivas-Santiago CE, Casteneda-Delgado JE, Leon-Contreras JC, Hancock REW, et al. (2012) Acivity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6, and CP 26 against Mycobacterium tuberculosis. Int J Antimicrob Agents dx.doi.org/10.1016.
24. Aaby P, Benn CS, (2011) Non-specific and sex-differential effects of routine vaccines: what evidence is needed to take these effects into consideration in low-income countries? Hum Vaccin 7: 120-124.
25. Aaby P, Samb B, Simondon F, Seck AM, Knudsen K, et al. (1995) Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 311: 481-485.
26. Olsen AW, Brandt L, Agger EM, van Pinxteren LA, Andersen P, (2004) The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Scand J Immunol 60: 273-277.
27. Leversen NA, Sviland L, Wiker HG, Mustafa T, (2012) Long-term persistence of BCG Pasteur in lungs of C57BL/6 mice following intranasal infection. Scand J Immunol 75: 489-499.
28. Mollenkopf HJ, Hahnke K, Kaufmann SH, (2006) Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect 8: 136-144.
29. Cirioni O, Ghiselli R, Tomasinsig L, Orlando F, Silvestri C, et al. (2008) Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa. Shock 30: 443-448.
30. Dean SN, Bishop B, van Hoek ML, (2011) Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 11: 114.
31. Sonawane A, Santos JC, Mishra BB, Jena P, Progida C, et al. (2011) Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell Microbiol 13: 1601-1617.
32. Kovach MA, Ballinger M, Newstead MW, Zeng X, Bhan U, et al. (2012) Cathelicidin-related antimicrobial Peptide is required for effective lung mucosal immunity in gram-negative bacterial pneumonia. J Immunol 189: 304-311.
33. Wuerth K, Hancock RE, (2011) New insights into cathelicidin modulation of adaptive immunity. Eur J Immunol 41: 2817-2819.
34. Jenssen H, Hancock RE, (2009) Antimicrobial properties of lactoferrin. Biochimie 91: 19-29.
35. Shakibaei M, Frevert U, (1996) Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans. J Exp Med 184: 1699-1711.
36. Fritsch G, Sawatzki G, Treumer J, Jung A, Spira DT, (1987) Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin. Exp Parasitol 63: 1-9.
37. Waters LS, Taverne J, Tai PC, Spry CJ, Targett GA, et al. (1987) Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun 55: 877-881.
38. Malik A, Batra J, (2012) Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens. Crit Rev Microbiol 38: 168-181.
39. Menezes-de-Lima-Júnior O, Werneck-Barroso E, Cordeiro RS, Henriques MG, (1997) Effects of inhibitors of inflammatory mediators and cytokines on eosinophil and neutrophil accumulation induced by Mycobacterium bovis bacillus Calmette-Guérin in mouse pleurisy. J Leukoc Biol 62: 778-785.
40. D'Avila H, Almeida P, Roque NR, Castro-Faria-Neto HC, Bozza PT, (2007) Toll-like receptor-2-mediated C-C chemokine receptor 3 and eotaxin-driven eosinophil influx induced by Mycobacterium bovis BCG pleurisy. Infect Immun 75: 1507-1511.
41. Goter-Robinson C, Derrick SC, Yang A, Jeon BY, Morris SL, (2006) Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses. Vaccine 24: 3522-3529.
42. Millington OR, Di Lorenzo C, Phillips RS, Garside P, Brewer JM, (2006) Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol 5: 5.
43. Were T, Davenport GC, Yamo EO, Hittner JB, Awandare GA, et al. (2009) Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism. Microbes Infect 11: 811-819.
44. Zheng W, Wang QH, Feng H, Liu J, Meng HR, et al. (2009) CD4+CD25+Foxp3+ regulatory T cells prevent the development of Th1 immune response by inhibition of dendritic cell function during the early stage of Plasmodium yoelii infection in susceptible BALB/c mice. Folia Parasitol 56: 242-250.
45. Chakravortty D, Hensel M, (2003) Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 5: 621-627.